Zusammenfassung
Patienten mit einer atopischer Dermatitis klagen häufig im Krankheitsverlauf über Beschwerden mit den Augen. Dabei ist zum einen die periokuläre Haut direkt an der Dermatitis beteiligt, und zum anderen kommt es häufig zu einer chronisch verlaufenden Blepharokeratokonjunktivitis. Die frühzeitige Diagnosestellung der charakteristischen ophthalmologischen Veränderungen (wie Blepharitis, allergische Konjunktivitis, Conjunctivitis sicca, Bindehautvernarbungen mit Symblepharonbildung und Lidfehlstellung, filiforme Keratitis, Bildung kornealer Plaques, [persistierende] Erosio, Hornhautulzera, Keratokonus etc.) und die entsprechende stadiengerechte Therapie (von der Lidrandpflege mit konservierungsmittelfreier Benetzung über eine topische und ggf. systemische antiinflammatorische Therapie bis zu chirurgischen Maßnahmen etc.) sind für die Betroffenen von großer Bedeutung, um langfristige Schäden an den Augen und eine damit einhergehende Sehbehinderung zu verhindern.
Abstract
Patients with atopic dermatitis frequently complain of ocular symptoms. The general dermatitis can directly affect the periocular skin and patients often present with chronic atopic blepharokeratoconjunctivitis. Early diagnosis of the characteristic ophthalmological alterations, such as blepharitis, allergic conjunctivitis, keratoconjunctivitis sicca, conjunctival scarring with formation of symblepharon and lid malpositioning, filiform keratitis, corneal plaques, (persistent) epithelial defects, corneal ulcers and keratoconus as well as appropriate stage-adapted treatment, including lid hygiene with preservative-free lubricants, topical and sometimes systemic anti-inflammatory therapy and surgical treatment are important for patients to prevent long-term damage of the ocular surface leading to severe visual impairment.
Literatur
Akpek EK, Dart JK, Watson S et al (2004) A randomized trial of topical cyclosporin 0.05 % in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology 111:476–482. doi:10.1016/j.ophtha.2003.05.035
Akyol-Salman I, Azizi S, Mumcu U, Baykal O (2010) Efficacy of topical N‑acetylcysteine in the treatment of meibomian gland dysfunction. J Ocul Pharmacol Ther 26:329–333. doi:10.1089/jop.2010.0001
Amemiya T, Matsuda H, Uehara M (1980) Ocular findings in atopic dermatitis with special reference to the clinical features of atopic cataract. Ophthalmologica 180:129–132
Auw-Hädrich C, Reinhard T (2009) Treatment of chronic blepharokeratoconjunctivitis with local calcineurin inhibitors. Ophthalmologe 106:635–638. doi:10.1007/s00347-009-1954-9
Bawazeer AM, Hodge WG, Lorimer B (2000) Atopy and keratoconus: a multivariate analysis. Br J Ophthalmol 84:834–836
Beetham WP (1940) Atopic cataracts. Arch Ophthalmol 24:21–37
BenEzra D, Pe’er J, Brodsky M, Cohen E (1986) Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis. Am J Ophthalmol 101:278–282
Bielory B, Bielory L (2010) Atopic dermatitis and keratoconjunctivitis. Immunol Allergy Clin North Am 30:323–336. doi:10.1016/j.iac.2010.06.004
Bielory L (2000) Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol 106:1019–1032. doi:10.1067/mai.2000.111238
Bleik JH, Tabbara KF (1991) Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology 98:1679–1684
Calonge M, Herreras JM (2007) Clinical grading of atopic keratoconjunctivitis. Curr Opin Allergy Clin Immunol 7:442–445. doi:10.1097/ACI.0b013e3282efd0bf
Coca AF, Cooke RA (1923) On classification of the phenomena of hypersensitiveness. J Immunol 8(3):163–182
Coles RS, Laval J (1952) Retinal detachments occurring in cataract associated with neurodermatitis. AMA Arch Ophthalmol 48:30–39
Cordes FC, Cordero-Moreno R (1946) Atopic cataracts; report of four cases. Am J Ophthalmol 29:402–407
Coster DJ (1997) Superficial keratopathy. In: Tasman W, Jaeger EA (Hrsg) Duane’s clinical opthalmology, Bd. 4. Lippincott-Raven, Philadelphia, S 1–13
Cursiefen C, Schaub F, Bachmann B (2016) Update: Deep anterior lamellar keratoplasty (DALK) for keratoconus. When, how and why. Ophthalmologe 113:204–212. doi:10.1007/s00347-015-0204-6
Darsow U, Wollenberg A, Simon D et al (2010) ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 24:317–328. doi:10.1111/j.1468-3083.2009.03415.x
Dogru M, Katakami C, Nakagawa N et al (1998) Impression cytology in atopic dermatitis. Ophthalmology 105:1478–1484. doi:10.1016/S0161-6420(98)98032-0
Dogru M, Nakagawa N, Tetsumoto K et al (1999) Ocular surface disease in atopic dermatitis. Jpn J Ophthalmol 43:53–57
Easty D, Entwistle C, Funk A, Witcher J (1975) Herpes simplex keratitis and keratoconus in the atopic patient. A clinical and immunological study. Trans Ophthalmol Soc U K 95:267–276
Eberwein P, Auw-Hadrich C, Birnbaum F et al (2008) Corneal melting after cross-linking and deep lamellar keratoplasty in a keratoconus patient. Klin Monbl Augenheilkd 225:96–98. doi:10.1055/s-2008-1027128
Foster CS, Calonge M (1990) Atopic keratoconjunctivitis. Ophthalmology 97:992–1000
Foster CS (1997) The eye in skin and mucous membrane disorders. In: Duane’s clinical opthalmology. Lippincott-Raven, Philadelphia, S 1–41
Fukushima A, Ohashi Y, Ebihara N et al (2014) Therapeutic effects of 0.1 % tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement. Br J Ophthalmol 98:1023–1027. doi:10.1136/bjophthalmol-2013-304453
Garrity JA, Liesegang TJ (1984) Ocular complications of atopic dermatitis. Can J Ophthalmol 19:21–24
Geggel HS (1994) Successful penetrating keratoplasty in a patient with severe atopic keratoconjunctivitis and elevated serum IgE level treated with long-term topical cyclosporin A. Cornea 13:543–545
Ghoraishi M, Akova YA, Tugal-Tutkun I, Foster CS (1995) Penetrating keratoplasty in atopic keratoconjunctivitis. Cornea 14:610–613
Gold MH, Picascia DD, Roenigk HHJ (1989) Treatment-resistant atopic dermatitis controlled with cyclosporin A. Int J Dermatol 28:481–482
Guglielmetti S, Dart JK, Calder V (2010) Atopic keratoconjunctivitis and atopic dermatitis. Curr Opin Allergy Clin Immunol 10:478–485. doi:10.1097/ACI.0b013e32833e16e4
Herbort CP, Zografos L, Zwingli M, Schoeneich M (1988) Topical retinoic acid in dysplastic and metaplastic keratinization of corneoconjunctival epithelium. Graefes Arch Clin Exp Ophthalmol 226:22–26
Hoang-Xuan T, Prisant O, Hannouche D, Robin H (1997) Systemic cyclosporine A in severe atopic keratoconjunctivitis. Ophthalmology 104:1300–1305
Hogan MJ (1952) Atopic keratoconjunctivitis. Trans Am Ophthalmol Soc 50:265–281
Hu Y, Matsumoto Y, Dogru M et al (2007) The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis. Allergy 62:917–925. doi:10.1111/j.1398-9995.2007.01414.x
Hurlbut WB, Domonkos AN (1954) Cataract and retinal detachment associated with atopic dermatitis. AMA Arch Ophthalmol 52:852–857
Johansson SGO, Bieber T, Dahl R et al (2004) Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113:832–836. doi:10.1016/j.jaci.2003.12.591
Kallen C, Reinhard T, Schilgen G et al (2003) Atopic keratoconjunctivitis: probably a risk factor for the development of conjuntival carcinoma. Ophthalmologe 100:808–814. doi:10.1007/s00347-003-0809-z
Kerr N, Stern GA (1992) Bacterial keratitis associated with vernal keratoconjunctivitis. Cornea 11:355–359
Klemens F (1962) Dermatosis, cataract and retinal detachment. Klin Monbl Augenheilkd Augenarztl Fortbild 140:657–663
Lang SJ, Böhringer D, Geerling G, Reinhard T (2016) Long-term results of allogenic penetrating limbo-keratoplasty: 20 years of experience. Eye (Lond). doi:10.1038/eye.2016.217
Lang SJ, Messmer EM, Geerling G et al (2015) Prospective, randomized, double-blind trial to investigate the efficacy and safety of corneal cross-linking to halt the progression of keratoconus. BMC Ophthalmol 15:78. doi:10.1186/s12886-015-0070-7
Leonardi A, De Dominicis C, Motterle L (2007) Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities. Curr Opin Allergy Clin Immunol 7:429–435. doi:10.1097/ACI.0b013e3282ef8674
Lyons CJ, Dart JK, Aclimandos WA et al (1990) Sclerokeratitis after keratoplasty in atopy. Ophthalmology 97:729–733
Mayer K, Reinhard T, Reis A et al (2001) FK 506 ointment 0.1 % – A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients. Klin Monbl Augenheilkd 218:733–736. doi:10.1055/s-2001-18665
Messner K, Leibowitz HM (1971) Acetylcysteine treatment of keratitis sicca. Arch Ophthalmol 86:357–359
Nanji AA, Sayyad FE, Karp CL (2013) Topical chemotherapy for ocular surface squamous neoplasia. Curr Opin Ophthalmol 24:336–342. doi:10.1097/ICU.0b013e3283622a13
Nelson MN (1988) Topical retinoic acid treatment for conjunctival squamous metaplasia. Arch Ophthalmol 106:1723
Nivenius E, van der Ploeg I, Jung K et al (2007) Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. Eye (Lond) 21:968–975. doi:10.1038/sj.eye.6702367
Ohashi Y, Ebihara N, Fujishima H et al (2010) A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1 % in severe allergic conjunctivitis. J Ocul Pharmacol Ther 26:165–174. doi:10.1089/jop.2009.0087
Power WJ, Tugal-Tutkun I, Foster CS (1998) Long-term follow-up of patients with atopic keratoconjunctivitis. Ophthalmology 105:637–642. doi:10.1016/S0161-6420(98)94017-9
Rahi A, Davies P, Ruben M et al (1977) Keratoconus and coexisting atopic disease. Br J Ophthalmol 61:761–764
Raizman MB, Rothman JS, Maroun F, Rand WM (2000) Effect of eye rubbing on signs and symptoms of allergic conjunctivitis in cat-sensitive individuals. Ophthalmology 107:2158–2161
Reinhard T, Reis A, Mayweg S et al (2002) Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study. Klin Monbl Augenheilkd 219:125–131. doi:10.1055/s-2002-26727
Reinhard T, Ruzicka T, Sundmacher R (1999) Pathogenesis, clinical aspects and therapy of eye involvement in allergy. Ophthalmologe 96:473–488
Reinhard T, Sundmacher R (1992) Perforating keratoplasty in endogenous eczema. An indication for systemic cyclosporin A – a retrospective study of 18 patients. Klin Monbl Augenheilkd 201:159–163. doi:10.1055/s-2008-1045885
Remitz A, Reitamo S (2009) Long-term safety of tacrolimus ointment in atopic dermatitis. Expert Opin Drug Saf 8:501–506. doi:10.1517/14740330902969441
Remitz A, Virtanen HM, Reitamo S, Kari O (2011) Tacrolimus ointment in atopic blepharoconjunctivitis does not seem to elevate intraocular pressure. Acta Ophthalmol 89:e295–e296. doi:10.1111/j.1755-3768.2009.01834.x
Rich LF, Hanifin JM (1985) Ocular complications of atopic dermatitis and other eczemas. Int Ophthalmol Clin 25:61–76
Rikkers SM, Holland GN, Drayton GE et al (2003) Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol 135:297–302
Roat MI, Ohji M, Hunt LE, Thoft RA (1993) Conjunctival epithelial cell hypermitosis and goblet cell hyperplasia in atopic keratoconjunctivitis. Am J Ophthalmol 116:456–463
Ruzicka T (1997) Atopie und atopisches Ekzem. In: Dermatologie und Venerologie, 4. Aufl. Springer, Berlin, S 445–460
Ruzicka T, Wüthrich B (1997) Das integrierte Therapiekonzept des atopischen Ekzems. Implementierung ganzheitlicher und naturheilkundlicher Prinzipien in der universitären Medizin. Dtsch Arztebl 94:A1874–A1880
Secchi AG, Tognon MS, Leonardi A (1990) Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol 110:641–645
Shields CL, Kaliki S, Kim HJ et al (2013) Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer Classification. Cornea 32:248–256. doi:10.1097/ICO.0b013e3182523f61
Sowden JM, Berth-Jones J, Ross JS et al (1991) Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 338:137–140
Tuft SJ, Kemeny DM, Dart JK, Buckley RJ (1991) Clinical features of atopic keratoconjunctivitis. Ophthalmology 98:150–158
Williams DL (1997) A comparative approach to topical cyclosporine therapy. Eye (Lond) 11(Pt 4):453–464. doi:10.1038/eye.1997.126
Zug KA, Palay DA, Rock B (1996) Dermatologic diagnosis and treatment of itchy red eyelids. Surv Ophthalmol 40:293–306
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
P. Maier, T. Lapp und T. Reinhard geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Maier, P., Lapp, T. & Reinhard, T. Augenbeteiligung bei atopischer Dermatitis. Ophthalmologe 114, 514–524 (2017). https://doi.org/10.1007/s00347-017-0473-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-017-0473-3